Kremers Urban Pharmaceuticals Inc. is aggressively pursuing both in-licensing generic
drug products and internal research and development.
The Company seeks strategic alliances in the development of products and drug delivery
technologies that would further enhance our capabilities or offerings. With a history
of marketing products with high barrier to entry, the strategy is to complement
Kremers Urban portfolio, which includes products such as Oxybutynin
Chloride Extended-Release Tablets USP, Omeprazole
Delayed-Release Capsules USP, Nifedipine Extended-Release Tablets USP, Temozolomide Capsules, and Verapamil Extended-Release
To discuss strategic partnering opportunities, please contact:
Director of Business Development
Lannett Company, Inc.
13200 Townsend Rd
Philadelphia, PA 19154
Phone (215) 333-9000